Results 11 to 20 of about 5,129 (208)

Ayahuasca’s ‘afterglow’: improved mindfulness and cognitive flexibility in ayahuasca drinkers [PDF]

open access: yesPsychopharmacology, 2020
Rationale: There is a growing body of evidence demonstrating the therapeutic potential of ayahuasca for treating depression and anxiety. However, the mechanisms of action involved in ayahuasca’s therapeutic effects are unclear.
Soar, Kirstie, Murphy-Beiner, A.
core   +3 more sources

Las propiedades farmacocinéticas del ayahuasca / The pharmacological properties of ayahuasca [PDF]

open access: yesLiberabit, 2015
RESUMEN Se describe las características químicas y los efectos del consumo del ayahuasca para conocer el estado actual de los descubrimientos existentes hasta la fecha sobre sus propiedades farmacocinéticas.
Guillermo Saúl Escobar Cornejo
doaj   +2 more sources

Ayahuasca

open access: yesCiencias Sociales y Religión/Ciências Sociais e Religião, 2021
O fenômeno de expansão do uso do yagé da América do Sul para o restante do mundo é caracterizado especialmente a partir da ideia da globalização da ahayuasca. No entanto, essa expansão foi mais recentemente acompanhada da configuração da ideia de uma comunidade ahayuasqueira internacional.
Deana Goldin, Deborah Salani
  +8 more sources

Registered Clinical Trials of Ayahuasca and DMT: A Scoping Review. [PDF]

open access: yesClin Pharmacol Ther
Interest in ayahuasca and its main component, N,N‐Dimethyltryptamine (DMT), has currently moved from historical and experimental use into modern clinical development. Yet, current evidence is fragmented, and systematic mapping of trial methods and design choices remains limited.
Stojanović T   +4 more
europepmc   +2 more sources

Psychedelics in Mental Health: Opportunities and Challenges. [PDF]

open access: yesBrain Behav
ABSTRACT Psychedelic and substance‐assisted therapies are attracting renewed scientific, clinical, and public interest as potential interventions for mental health disorders, particularly treatment‐resistant depression, post‐traumatic stress disorder, and substance use disorders.
Oestreich LKL, Rieser NM.
europepmc   +2 more sources

Music Playlist Use in Clinical Trials of Psychedelic Assisted Psychotherapy: A Systematic Review. [PDF]

open access: yesJ Clin Psychol
ABSTRACT Recent studies have shown promising results for psychedelics in the treatment of psychiatric disorders. Both in clinical and recreational settings, contextual elements, such as music, can influence the experience of users and may be linked to positive outcomes.
Cruz L   +4 more
europepmc   +2 more sources

Evaluation of the Cytotoxicity of Ayahuasca Beverages [PDF]

open access: yes, 2020
Ayahuasca is a beverage consumed at shamanic ceremonies and currently has gained popularity on recreational scenarios. It contains beta-carboline alkaloids and N,N-dimethyltryptamine, which possesses hallucinogenic effects.
Gradillas, Ana   +21 more
core   +1 more source

No-ayahuasca

open access: yes, 2022
Pearson's connection matrix of the EEG experiments of subjects who ingested Ayahuasca at the time before the psychedelic activation time.
Caroline Alves (12018389)
core   +1 more source

With-ayahuasca

open access: yes, 2022
Pearson's connection matrix of the EEG experiments of subjects who ingested Ayahuasca at the time after the psychedelic activation time.
Caroline Alves (12018389)
core   +1 more source

Pre-clinical interaction of ayahuasca, a brew used in spiritual movements, with morphine and propofol

open access: yesBrazilian Journal of Pharmaceutical Sciences, 2018
Ayahuasca is a beverage with psychoactive properties used in religious and ceremonial rituals by some religious groups. The main active components of ayahuasca are dimethyltryptamine and the harmala alkaloids with β-carboline structure acting as ...
Júlia Movilla Pires   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy